Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalKidney TransplantationLeukemiaTissue DonorsTransplantation ChimeraLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHematopoietic Stem CellsHistocompatibilityGraft RejectionCyclophosphamideTransplantation, IsogeneicImmunosuppressive AgentsBone Marrow DiseasesHematopoiesisTime FactorsRecurrenceTreatment OutcomeMice, Inbred C57BLCombined Modality TherapyHeart TransplantationT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraLeukemia, Myeloid, AcuteHematologic NeoplasmsImmunosuppressionBone Marrow ExaminationTransplantation ImmunologyRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationHepatic Veno-Occlusive DiseaseAcute DiseaseLeukemia, MyeloidStem Cell TransplantationBone RemodelingLymphocyte DepletionRetrospective StudiesLymphoma, Non-HodgkinBone Marrow NeoplasmsGraft vs Host ReactionCyclosporineLeukocyte TransfusionHLA AntigensColony-Forming Units AssayFlow CytometryLeukocytes, MononuclearSurvival AnalysisLeukocyte CountChimeraSevere Combined ImmunodeficiencyCells, CulturedMyelodysplastic SyndromesCytomegalovirus InfectionsPeripheral Blood Stem Cell TransplantationHematologic DiseasesFollow-Up StudiesGranulocyte Colony-Stimulating FactorLymphocyte TransfusionLymphocytesCell DifferentiationActuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsBlood CellsTransplantationBone DensitySurvival RateNuclear FamilyAntigens, CD34SpleenTransplantsCarmustineImmunophenotypingPancytopeniaMice, Inbred BALB CGraft vs Tumor EffectCytarabineOrgan TransplantationMelphalanGraft vs Leukemia EffectMultiple MyelomaLymphomaDisease-Free SurvivalAntibodies, MonoclonalCell SeparationLymphocyte Activation